OX40 Agonist BMS-986178 Alone or in Combination With Nivolumab and/or Ipilimumab in Patients With Advanced Solid Tumors

Added 246 days ago (19.01.2021)
Authors: Gutierrez, M., Moreno, V., Heinhuis, K. M., Olszanski, A. J., Spreafico, A., Ong, M., Chu, Q., Carvajal, R. D., Trigo, J., De Olza, M. O., Provencio, M., De Vos, F. Y., De Braud, F., Leong, S., Lathers, D., Wang, R., Ravindran, P., Feng, Y., Aanur, P., Melero, I.
Read article